Literature DB >> 17338599

Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.

Sandra Baker Morissette1, Matthew T Tull, Suzy Bird Gulliver, Barbara Wolfsdorf Kamholz, Rose T Zimering.   

Abstract

Smoking is highly prevalent across most anxiety disorders. Tobacco use increases risk for the later development of certain anxiety disorders, and smokers with anxiety disorders have more severe withdrawal symptoms during smoking cessation than smokers without anxiety disorders. The authors critically examined the relationships among anxiety, anxiety disorders, tobacco use, and nicotine dependence and reviewed the existing empirical literature. Future research is needed to better understand the interrelationships among these variables, including predictors, moderators, and mechanisms of action. Increased knowledge in these areas should inform prevention efforts as well as the development and improvement of smoking cessation programs for those with anxiety and other psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338599     DOI: 10.1037/0033-2909.133.2.245

Source DB:  PubMed          Journal:  Psychol Bull        ISSN: 0033-2909            Impact factor:   17.737


  119 in total

Review 1.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder.

Authors:  Timothy P Carmody; Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Anne M Joseph; Jean C Beckham; Jessica W Cook
Journal:  Nicotine Tob Res       Date:  2012-01-23       Impact factor: 4.244

3.  Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women.

Authors:  Miriam K Forbes; Julianne C Flanagan; Emma L Barrett; Erica Crome; Andrew J Baillie; Katherine L Mills; Maree Teesson
Journal:  Drug Alcohol Depend       Date:  2015-09-14       Impact factor: 4.492

4.  Menstrual symptoms in adolescent girls: association with smoking, depressive symptoms, and anxiety.

Authors:  Lorah D Dorn; Sonya Negriff; Bin Huang; Stephanie Pabst; Jennifer Hillman; Paula Braverman; Elizabeth J Susman
Journal:  J Adolesc Health       Date:  2008-10-29       Impact factor: 5.012

5.  Social and generalized anxiety symptoms and alcohol and cigarette use in early adolescence: the moderating role of perceived peer norms.

Authors:  Jennifer M Zehe; Craig R Colder; Jennifer P Read; William F Wieczorek; Liliana J Lengua
Journal:  Addict Behav       Date:  2012-12-13       Impact factor: 3.913

6.  Is smoking tobacco associated with psychotic experiences across racial categories in the United States? Findings from the Collaborative Psychiatric Epidemiological Surveys.

Authors:  Hans Y Oh; Ai Koyanagi; Fiza Singh; Jordan DeVylder
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

7.  PTSD symptomatology and readiness to quit smoking among women with serious mental illness.

Authors:  Kelly C Young-Wolff; Sebastien C Fromont; Kevin Delucchi; Stephen E Hall; Sharon M Hall; Judith J Prochaska
Journal:  Addict Behav       Date:  2014-04-05       Impact factor: 3.913

8.  Smoking processes, panic, and depressive symptoms among treatment-seeking smokers.

Authors:  Dawn W Foster; Kirsten J Langdon; Norman B Schmidt; Michael Zvolensky
Journal:  Subst Use Misuse       Date:  2014-12-15       Impact factor: 2.164

9.  Nicotine sensitization (Part 2): Time spent in the centre of an open field sensitizes to repeated nicotine into the drug-free state in female rats.

Authors:  Jennet L Baumbach; Cheryl M McCormick
Journal:  Psychopharmacology (Berl)       Date:  2020-10-29       Impact factor: 4.530

10.  Racial differences in alcohol and tobacco use in adolescence and mid-adulthood in a community-based sample.

Authors:  John R Pamplin; Ezra S Susser; Pam Factor-Litvak; Bruce G Link; Katherine M Keyes
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-09-21       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.